Cholesterol is a ubiquitous membrane component in biology. In lipid bilayers it intercalates between phospholipids, tightening packing and modulating fluidity, elasticity, and permeability. In simple terms, it can “fill” packing defects created by imperfectly ordered lipids or by embedded proteins. Model membranes—liposomes—show the same general behavior: appropriate amounts of cholesterol typically reduce permeability and leakage and enhance mechanical robustness.

• Sourcing & suitability for pharma

Where the original concerns arise is on the pharmaceutical side. Historically, high-purity cholesterol was often sourced from animal materials such as egg or lanolin, which raised questions about adventitious agents and supply consistency. Today, however, GMP/compendial-grade plant-derived and synthetic cholesterols are widely available, and animal-derived materials can also be suitable when suppliers provide the required traceability and risk assessments (e.g., viral/TSE controls). In other words, cholesterol itself isn’t inherently unsuitable for human use; it simply requires the same quality and documentation standards as other critical excipients.

• Oxidation risk & control strategies

One real drawback is oxidation. Cholesterol can autoxidize during processing and storage to form oxysterols—such as 7-ketocholesterol, 7α/7β-hydroxycholesterol, 25-hydroxycholesterol, cholestane-3β,5α,6β-triol, and related hydroperoxides. Several of these species are biologically active and can be cytotoxic. For lipid-based drug products, that means oxidation control and analytical monitoring are essential. Good practice includes minimizing exposure to heat, light, and oxygen; using inert-gas blanketing and amber packaging; limiting residence time at elevated temperatures; and, where justified, adding a low-level antioxidant (e.g., α-tocopherol) with supporting compatibility/stability data.

These oxidation issues also matter for interpretation of research. If cholesterol (or high-cholesterol diets) is stored under adverse conditions—at room temperature and open to air—meaningful amounts of oxysterols can accumulate. Studies that feed such material to animals may therefore be confounded by oxidized sterols rather than cholesterol itself, which can complicate conclusions about atherosclerosis.

Bottom line: Cholesterol usually offers clear advantages in liposome design—lower permeability, improved mechanical stability, and tunable membrane order. The disadvantages are manageable and center on sourcing/quality documentation and oxidation control. Using reputable GMP-grade (including non-animal) cholesterol and implementing thoughtful handling, packaging, and stability testing lets you capture the benefits while minimizing risk.

Aladdin：https://www.aladdinsci.com/